Skip to content

ABSOLVER study

feAsiBility of Sensing endOvascuLar Vagus-evoked rEsponses via the exteRnal neurostimulator system during surgery or ICU stay - The ABSOLVER study - ABSOLVER Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON58464
Enrollment
10
Registered
2025-10-10
Start date
2026-06-05
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy, seizure disorder, convulsive disorder, convulsions, seizures Depression, (major) depressive disorder, clinical depression Stroke, cerebrovascular accident (CVA), stroke rehabilitation, motor rehabilitation Rheumatoid arthritis, autoimmune arthritis Epilepsy Depression Stroke Arthritis

Interventions

Electrical stimulation will be delivered to the vagus nerve through electrodes on an Achieve Advance mapping catheter that is placed temporarily in the IJV. Stimulation will be delivered to the Achiev

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Subjects 18 – 35 years old.Body mass index (BMI) =18 and =30 kg/m2Healthy (as determined by medical history, physical examination, vital signs, 12-lead electrocardiogram and routine clinical laboratory parameters)Able to comprehend and sign the information letter and Informed Consent (IC) prior to enrolment in the study

Exclusion criteria

Exclusion criteria: Any active implanted devicePregnancy or lactatingVascular acces issues regarding the left internal jugular veinMRI contraindicationsAny active disease that causes some form of inflammation, recent (<1 month) acute illness, including infections or trauma and recent (<3 months) hospital admission or surgery with general anesthesiaAny active diseases or symptoms that need medication therapy (over the counter medication included), except for contraceptive methodsRecent (<3 months) participation in another experimental studyHistory, signs or symptoms of neurological, hematological or cardiovascular disease

Design outcomes

Primary

MeasureTime frame
The primary study endpoint is the proportion of subjects with measurable endovascular vagus stimulation evoked compound action potentials.

Secondary

MeasureTime frame
Secondary measures include characterizing the changes in physiologic and immunological parameters such as blood pressure, ECG, and inflammatory cytokines with stimulation. 

Countries

Netherlands

Contacts

Public ContactJ Koolen

Radboud Universitair Medisch Centrum

studies.ic@radboudumc.nl+31243668420

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jun 21, 2026